Posts

Showing posts from October, 2026

Drug Discovery Consulting and Clinical Trial Consulting: What Sponsors Should Know Before Engaging an Advisor

  Drug discovery consulting and clinical trial consulting both help organizations make better decisions in a field where decisions are expensive and hard to reverse. Discovery-stage teams ask whether a target and candidate justify further investment. Clinical teams ask whether a trial design, site strategy, and data plan can answer the questions regulators and payers will care about. This article explains what each type of advisory typically covers, how they connect, and how to select and measure a partner. What Drug Discovery Consulting Typically Involves Drug discovery consulting supports the early path from biological hypothesis to development candidate. Common areas include: •       Target identification and validation: reviewing the evidence that a target is relevant to a disease and tractable. •       Assay and screening strategy: assessing whether experiments will produce reliable, decision-ready data. •       Hit-to-lead an...